These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6457070)

  • 1. Impaired antigen-specific suppressor cell activity in psoriasis and psoriatic arthritis.
    Gladman DD; Keystone EC; Russell ML; Schachter RK
    J Invest Dermatol; 1981 Nov; 77(5):406-9. PubMed ID: 6457070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrations in T-cell subpopulations in patients with psoriasis and psoriatic arthritis.
    Gladman DD; Keystone EC; Schacter RK
    J Invest Dermatol; 1983 Apr; 80(4):286-90. PubMed ID: 6601167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired antigen-specific suppressor cell activity in patients with rheumatoid arthritis.
    Keystone EC; Gladman DD; Buchanan R; Cane D; Poplonski L
    Arthritis Rheum; 1980 Nov; 23(11):1246-50. PubMed ID: 6160858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency of HLA antigens in patients with psoriasis or psoriatic arthritis.
    McKendry RJ; Sengar DP; DesGroseilliers JP; Dunne JV
    Can Med Assoc J; 1984 Feb; 130(4):411-5. PubMed ID: 6692237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired antigen-specific suppressor cell activity in patients with systemic lupus erythematosus.
    Gladman D; Keystone E; Urowitz M; Cane D; Poplonski L
    Clin Exp Immunol; 1980 Apr; 40(1):77-82. PubMed ID: 6156046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA antigens in psoriatic arthritis.
    Gladman DD; Anhorn KA; Schachter RK; Mervart H
    J Rheumatol; 1986 Jun; 13(3):586-92. PubMed ID: 3735281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lymphocyte subpopulations in psoriatic arthritis].
    Schnabel I; Hein G
    Z Gesamte Inn Med; 1984 Nov; 39(21):539-40. PubMed ID: 6240838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low frequency of anticyclic citrullinated peptide antibodies in psoriatic arthritis but not in cutaneous psoriasis.
    Candia L; Marquez J; Gonzalez C; Santos AM; Londoño J; Valle R; Zabaleta J; Yaqub Z; Espinoza LR
    J Clin Rheumatol; 2006 Oct; 12(5):226-9. PubMed ID: 17023808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marked increase in the frequency of psoriatic arthritis in psoriasis patients with HLA-DR+ keratinocytes.
    Gottlieb AB; Fu SM; Carter DM; Fotino M
    Arthritis Rheum; 1987 Aug; 30(8):901-7. PubMed ID: 2443147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired function of regulatory T cells in patients with psoriasis is mediated by phosphorylation of STAT3.
    Yang L; Li B; Dang E; Jin L; Fan X; Wang G
    J Dermatol Sci; 2016 Feb; 81(2):85-92. PubMed ID: 26627723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between HLA-BW38 and peripheral psoriatic arthritis.
    Espinoza LR; Vasey FB; Oh JH; Wilkinson R; Osterland CK
    Arthritis Rheum; 1978; 21(1):72-5. PubMed ID: 623697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A possible pathogenic role of CD4+CD25+ T-regulatory cells in psoriasis.
    Shehata IH; Elghandour TM
    Egypt J Immunol; 2007; 14(1):21-31. PubMed ID: 18689278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective analysis of psoriatic arthritis in patients hospitalized for psoriasis.
    Leonard DG; O'Duffy JD; Rogers RS
    Mayo Clin Proc; 1978 Aug; 53(8):511-8. PubMed ID: 682678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Etiopathogenetic aspects of psoriatic arthritis with special reference to immunologic factors].
    Hein G; Henzgen M; Vogelsang H; Knopf B
    Z Gesamte Inn Med; 1984 Nov; 39(21):537-9. PubMed ID: 6240837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cellular and humoral immune phenomena in psoriatic arthritis].
    Neumüller J; Senautka G; Dunky A; Neumann H; Mayer F; Much T; Eberl R; Partsch G
    Wien Klin Wochenschr; 1983 Jun; 95(12):416-22. PubMed ID: 6604367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psoriatic arthritis and HLA antigens.
    Roux H; Mercier P; Maestracci D; Serratrice G; Sany J; Seignalet J; Serre H
    J Rheumatol Suppl; 1977; 3():64-5. PubMed ID: 266601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Psoriatic arthritis: considerations on recent studies: serum beta 2 microglobulin and circulating T-gamma lymphocytes].
    Mathieu A; Aste N; Pala R; Biggio P; Carcassi C; Piga M; Mereu MC; Pisano L
    Boll Ist Sieroter Milan; 1983 Sep; 62(4):344-9. PubMed ID: 6362682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressor function of peripheral blood mononuclear cells in patients with psoriasis vulgaris.
    Hunyadi J; Dobozy A; Kenderessy AS; Simon N
    J Invest Dermatol; 1980 Sep; 75(3):217-8. PubMed ID: 6447736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-mediated immunity in psoriatic arthritis.
    Espinoza LR; Gaylord SW; Vasey FB; Osterland CK
    J Rheumatol; 1980; 7(2):218-24. PubMed ID: 6966333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Synovial level of interleukin 1 and C3a in chronic polyarthritis, psoriatic arthritis and activated arthritis].
    Hermann E; Vogt P; Hagmann W; Dunky A; Müller W
    Z Rheumatol; 1988; 47(1):20-5. PubMed ID: 3259355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.